CX Institutional’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Hold
531
﹤0.01% 1248
2026
Q1
$7K Hold
531
﹤0.01% 1331
2025
Q4
$6K Hold
531
﹤0.01% 1246
2025
Q3
$6K Hold
531
﹤0.01% 1245
2025
Q2
$6K Hold
531
﹤0.01% 1088
2025
Q1
$8K Buy
+531
New +$8.29K ﹤0.01% 1030
2022
Q3
Sell
-525
Closed -$14K 501
2022
Q2
$14K Buy
+525
New +$15.1K ﹤0.01% 895
2021
Q4
Sell
-525
Closed -$16K 373
2021
Q3
$16K Hold
525
﹤0.01% 770
2021
Q2
$19K Hold
525
﹤0.01% 743
2021
Q1
$23K Hold
525
﹤0.01% 644
2020
Q4
$24K Sell
525
-6
-1% -$250 ﹤0.01% 575
2020
Q3
$18K Buy
531
+6
+1% +$192 ﹤0.01% 563
2020
Q2
$15K Hold
525
﹤0.01% 498
2020
Q1
$14K Hold
525
﹤0.01% 418
2019
Q4
$18K Hold
525
﹤0.01% 355
2019
Q3
$20K Sell
525
-24
-4% -$916 ﹤0.01% 373
2019
Q2
$24K Buy
549
+24
+5% +$1.03K ﹤0.01% 382
2019
Q1
$22K Sell
525
-6
-1% -$269 ﹤0.01% 394
2018
Q4
$24K Buy
+531
New +$27.8K 0.01% 308

Other funds holding AVNS

CX Institutional's AVNS Position: Q2 2026 in Review

CX Institutional held its Avanos Medical (AVNS) position steady in Q2 2026 at 531 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

CX Institutional first reported a position in AVNS in Q4 2018 and has held it in 19 quarters since. The position peaked at $24K in Q4 2020. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • CX Institutional held 531 shares of Avanos Medical worth $13K as of Q2 2026.
  • CX Institutional left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of CX Institutional's portfolio in Q2 2026, its #1248 holding.
  • CX Institutional first reported a position in Avanos Medical in Q4 2018 and has held it in 19 quarters since.
  • CX Institutional's Avanos Medical position peaked at $24K in Q4 2020.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.